ENFOQUS

Serial Number 98416390
731

Registration Progress

Application Filed
Feb 22, 2024
Under Examination
Jul 16, 2024
Approved for Publication
May 21, 2024
Published for Opposition
May 21, 2024
Registered

Basic Information

Serial Number
98416390
Deadline
January 16, 2026
Description
Statement of Use or 3rd Extension Due
Filing Date
February 22, 2024
Published for Opposition
May 21, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
731
Status Date
Jun 10, 2025
Application
Pending
Classes
005

Rights Holder

Cingulate Therapeutics LLC

16
Address
1901 W 47th Place, Suite 310
Kansas City, KS 66205

Ownership History

Cingulate Therapeutics LLC

Original Applicant
16
Kansas City, KS

Cingulate Therapeutics LLC

Owner at Publication
16
Kansas City, KS

Legal Representation

Attorney
Susan Neuberger Weller
USPTO Deadlines
All 4 deadline(s) have been cleared by subsequent events. No active renewal deadlines at this time.

Application History

21 events
Date Code Type Description
Jun 10, 2025 EX2G S SOU EXTENSION 2 GRANTED
Jun 10, 2025 EEXT I SOU TEAS EXTENSION RECEIVED
Jun 10, 2025 EXT2 S SOU EXTENSION 2 FILED
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 27, 2024 EX1G S SOU EXTENSION 1 GRANTED
Nov 26, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Nov 26, 2024 EXT1 S SOU EXTENSION 1 FILED
Jul 16, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 21, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 21, 2024 PUBO A PUBLISHED FOR OPPOSITION
May 1, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 16, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 12, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 12, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 12, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 29, 2024 CNRT R NON-FINAL ACTION WRITTEN
Mar 29, 2024 DOCK D ASSIGNED TO EXAMINER
Mar 29, 2024 GNRT F NON-FINAL ACTION E-MAILED
Feb 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 22, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder (ADHD)

Classification

International Classes
005